APEX1 and breast cancer: Inhibition of APE1/Ref1 redox signaling reduces the BC cell proliferation and that enhances the therapeutic effect of cisplatin on BC cells, suggesting that APE1/Ref1 is a good drug target for the treatment of BC73.